Targeted inhibition of FGF19/FGFR cascade improves antitumor immunity and response rate in hepatocellular carcinoma.
Hepatol Int
; 15(5): 1236-1246, 2021 Oct.
Article
in En
| MEDLINE
| ID: mdl-34333737
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Hepatocellular
/
Liver Neoplasms
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Hepatol Int
Year:
2021
Type:
Article
Affiliation country:
Singapore